Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
SUBSCRIBE
Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
Global Market Bulletin
No Result
View All Result
Home Stock Market News

Top 10 Stocks Jim Cramer Is Watching Right Now

by Global Market Bulletin
February 27, 2026
in Stock Market News
0
Top 10 Stocks Jim Cramer Is Watching Right Now

Top 10 Stocks Jim Cramer Is Watching Right Now

77
SHARES
167
VIEWS
Share on FacebookShare on Twitter

2. The TJX Companies Inc. (NYSE:TJX)

The TJX Companies, Inc. continues to reinforce its reputation as one of the most resilient names in the retail sector, with shares recently trading around $159.59 after delivering what Jim Cramer described as a “terrific quarter.” Despite broader market volatility that pressured retailers, credit card stocks, banks, and travel names, TJX stock demonstrated the operational strength that has long defined its off-price retail model. Cramer has publicly reiterated his confidence in the company, highlighting the exceptional performance of HomeGoods, Marshalls, and T.J. Maxx, even as he advised investors to wait for tactical pullbacks before adding to positions. His view underscores a key point: short-term price fluctuations do not diminish the long-term investment thesis.

You might also like

Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?

Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

TJX Companies operates a powerful off-price retail ecosystem, selling apparel, footwear, accessories, and home goods at compelling value, a strategy that consistently drives strong same-store sales and high inventory turnover. In an uncertain macroeconomic environment where consumers are increasingly value-conscious, the off-price retail model tends to outperform traditional department stores. The company’s ability to source branded merchandise at attractive costs and pass savings to customers gives TJX a structural competitive advantage. HomeGoods’ standout performance, combined with steady traffic at Marshalls and T.J. Maxx, highlights diversified revenue streams across apparel and home categories.

While management typically offers cautious forward guidance on earnings calls, this conservatism has historically set a low bar that TJX often surpasses, reinforcing investor confidence in execution. Even amid broader concerns about automation and long-term labor market shifts, Cramer has dismissed the notion of an immediate white-collar job apocalypse, noting that consumer-driven businesses like TJX should recover alongside broader retail sentiment. For long-term investors, the key attraction lies in TJX’s consistent earnings growth, disciplined inventory management, global expansion opportunities, and strong free cash flow generation.

As one of the leading off-price retail stocks in the S&P 500, TJX combines defensive consumer appeal with scalable growth potential. Temporary market pullbacks may offer attractive entry points, but the underlying fundamentals remain intact. With strong brand positioning, proven management execution, and endorsement from prominent market commentators, TJX stock continues to stand out as a high-quality retail investment positioned for sustained long-term growth.

Click next to see the following stock...

Page 7 of 8
Prev1...678Next
Tags: American Express Company (NYSE:AXP)Arista Networks Inc (NYSE:ANET)Marriott International Inc. (NASDAQ:MAR)NVIDIA Corporation (NASDAQ:NVDA)Salesforce Inc. (NYSE:CRM)Snowflake Inc. (NYSE:SNOW)The TJX Companies Inc. (NYSE:TJX)Top 10 Stocks Jim Cramer Is Watching Right NowVisa Inc. (NYSE:V)Wells Fargo & Company (NYSE:WFC)Yum! Brands Inc. (NYSE:YUM)
Share31Tweet19

Global Market Bulletin

Global Market Bulletin is a leading provider of stock market updates, economic news, and personalized investing guides. Our team brings you the latest global financial information to help you make smart investment decisions. About the Editorial Team Our editorial team consists of financial experts and seasoned market analysts who bring decades of experience to our coverage. With a commitment to unbiased reporting, our team ensures that every article is backed by thorough research and delivers accurate financial insights.

Recommended For You

Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

by Global Market Bulletin
June 6, 2026
0
Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?

by Global Market Bulletin
June 6, 2026
0
Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

by Global Market Bulletin
June 6, 2026
0
Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Is Bob’s Discount Furniture (BOBS) a Good Retail Stock to Buy for Long-Term Growth?

by Global Market Bulletin
June 6, 2026
0
Is Bob’s Discount Furniture (BOBS) a Good Retail Stock to Buy for Long-Term Growth?

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Here’s What Makes Intellia Therapeutics (NTLA) a High-Risk, High-Reward Stock for Long-Term Investors

by Global Market Bulletin
June 6, 2026
0
Here’s What Makes Intellia Therapeutics (NTLA) a High-Risk, High-Reward Stock for Long-Term Investors

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Browse by Category

  • CEO Interviews
  • Economy
  • Investing
  • Stock Market News
  • Uncategorized

QUICK LINKS

  • Stock Market News
  • Investing
  • Economy
  • Contact Us
  • About Global Market Bulletin
  • Editorial Policy – Global Market Bulletin
  • Our Editorial Team

RECENT POSTS

  • Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy
  • Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?
  • Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

GET EMAIL MARKET UPDATES

Subscribe to our mailing list to receives daily updates direct to your inbox!
  • Privacy Policy
  • Terms and Conditions

© 2022 Global Market Bulletin. All Rights Reserved.

No Result
View All Result
  • Home
  • Stock Market News
  • Investing
  • Economy

© 2022 Global Market Bulletin. All Rights Reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?